Journal profile · Cell Biology

ACTA HISTOCHEMICA ET CYTOCHEMICA

ISSN 0044-5991 · eISSN 1347-5800 · Japan Society of Histochemistry and Cytochemistry · JAPAN · Bimonthly · Founded 1968

ACTA HISTOCHEMICA ET CYTOCHEMICA: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 1.88; fully open access; median 47 days to acceptance (34 articles, last 24 months); community-reported acceptance: easy; 22 articles in 2025; indexed in SCIE and Scopus.

Impact factor1.88Latest value listed by LetPub
CAS zoneZone 4 · Biology2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Biology
Review time47 daysMedian, submission to acceptance · 34 articles, last 24 months · PubMed
APC—No source gives fee information
AcceptanceEasyCommunity average
Articles per year222025 · OpenAlex count

Scope

Aims, scope and focus

ACTA HISTOCHEMICA ET CYTOCHEMICA is published by Japan Society of Histochemistry and Cytochemistry and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glycosylation and Glycoproteins Research, Molecular Biology Techniques and Applications and Neuroscience and Neuropharmacology Research, together about 21.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Acta Histochemica et Cytochemica is the official online journal of the Japan Society of Histochemistry and Cytochemistry. It is intended primarily for rapid publication of concise, original articles in the fields of histochemistry and cytochemistry. Manuscripts oriented towards methodological subjects that contain significant technical advances in these fields are also welcome. Manuscripts in English are accepted from investigators in any country, whether or not they are members of the Japan Society of Histochemistry and Cytochemistry. Manuscripts should be original work that has not been previously published and is not being considered for publication elsewhere, with the exception of abstracts. Manuscripts with essentially the same content as a paper that has been published or accepted, or is under consideration for publication, will not be considered. All submitted papers will be peer-reviewed by at least two referees selected by an appropriate Associate Editor. Acceptance is based on scientific significance, originality, and clarity. When required, a revised manuscript should be submitted within 3 months, otherwise it will be considered to be a new submission. The Editor-in-Chief will make all final decisions regarding acceptance.

Source: LetPub

Research area (LetPub): Cell Biology

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology9.5%
  2. Molecular Biology Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology6%
  3. Neuroscience and Neuropharmacology ResearchNeuroscience5.9%
  4. Pancreatic function and diabetesMedicine5.4%
  5. Monoclonal and Polyclonal Antibodies ResearchMedicine5%
  6. Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology4.5%
  7. Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.3%
  8. Erythrocyte Function and PathophysiologyMedicine4.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
LevelCategoryZone
MajorBiologyZone 4
MinorCell BiologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Biology Zone 4
LevelCategoryZone
MajorBiologyZone 4
MinorCell BiologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
LevelCategoryZone
MajorBiologyZone 4
MinorCell BiologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
1.88LetPub ·
CiteScore 2026-06
3.1LetPub ·
SJR 2026-06
0.73LetPub ·
SNIP 2026-06
0.74LetPub ·
h-index
23LetPub ·
h-index
47OpenAlex ·
i10-index
622OpenAlex ·
2-year mean citedness
2.31OpenAlex ·
Self-citation rate
5.3%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
19LetPub ·

Articles by year OpenAlex count · 5,638 in total · the current year is incomplete

YearArticlesOpen accessCitations
202614142
2025222237
2024222295
2023202096
20222121207
20212121264

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

47 daysMedian, submission to acceptance · P25–P75 18 days – 99 days

Acceptance to online
median 48 days (30 articles)
Submission to online
median 100 days
Sample
34 articles with submission and acceptance dates (42 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessOpenAlex

Every article is open access; authors usually pay an article processing charge (APC).

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Policy excerpts from the journal's websiteSelf-archiving
Self-archiving Release delay (Embargo)

Typically, articles are not available in PMC until after the publisher's embargo period. However, in some cases articles may be available in PMC sooner than the default period.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Japan Society of Histochemistry and Cytochemistry
Country or region
JAPAN
Language
English
Frequency
Bimonthly
Founded
1968
ISSN
0044-5991
Electronic ISSN
1347-5800
Official links

FAQ

Frequently asked questions about ACTA HISTOCHEMICA ET CYTOCHEMICA

What CAS zone is ACTA HISTOCHEMICA ET CYTOCHEMICA in?

In the 2025 upgraded edition of the CAS Journal Ranking, ACTA HISTOCHEMICA ET CYTOCHEMICA is in Zone 4 of Biology, and in Zone 4 of the minor category Cell Biology. In the 2026 Xinrui edition it is in Zone 4 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of ACTA HISTOCHEMICA ET CYTOCHEMICA?

The latest impact factor listed by LetPub is 1.88; CiteScore 3.1, h-index 47.

How long does peer review take at ACTA HISTOCHEMICA ET CYTOCHEMICA?

Based on the dates recorded on 34 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 47 days (interquartile range 18–99 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index ACTA HISTOCHEMICA ET CYTOCHEMICA?

According to LetPub and DOAJ records, ACTA HISTOCHEMICA ET CYTOCHEMICA is indexed in SCIE and Scopus.

Is ACTA HISTOCHEMICA ET CYTOCHEMICA open access, and what is the APC?

ACTA HISTOCHEMICA ET CYTOCHEMICA is a fully open-access journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .